Статья
Тромбоз ушка левого предсердия при фибрилляции предсердий - современное состояние проблемы
Выполнен обзор литературы по проблеме тромбоза ушка левого предсердия при фибрилляции предсердий, рассмотрены морфо-функциональные характеристики ушка левого предсердия, определяющие высокий риск тромбообразования, приведены данные исследований по эффективности антикоагулянтной терапии в профилактике и лечении тромбоза ушка левого предсердия.
1. Mahmood S.S., Levy D., Vasan R.S., Wang T.J. The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A Historical Perspective. Lancet;2014; 383(9921): 999-1008. https://doi.org/10.1016/S01406736(13)61752-3.
2. Wyndham C.R. Atrial fibrillation: the most common arrhythmia. Texas Heart Institute Journal. 2000;27(3):257-67.
3. Lloyd-Jones D., Adams R.J., Brown T.M. et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 121; e46-e215. Available at: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.109.192667. Accessed May 10, 2019.
4. Lip G.Y. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. Journal Thrombosis and Heamostasis. 2011; 9 (Suppl 1): 344-351. https://doi.org/10.1111/j.1538-7836.2011.04302.x.
5. Thambidorai S.K., Murray R.D., Parakh K. et al. Utility of Transesophageal Echocardiography in Identification of Thrombogenic Milieu in Patients With Atrial Fibrillation (an ACUTE Ancillary Study). American Journal of Cardiology. 2005;96:935-941. https://doi.org/10.1016/j.amjcard.2005.05.051.
6. Andrade J.G., Macle L., Nattel S. et al. Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines. The Canadian journal of cardiology. 2017;33:965-76. https://doi.org/10.1016/j.cjca.2017.06.002.
7. Al-Saady N.M., Obel O.A., Camm A.J. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999;82:547-555. http://dx.doi.org/10.1136/hrt.82.5.547.
8. Beigel R., Wunderlich N.C., Ho S.Y. et al. The Left Atrial Appendage: Anatomy, Function, and Noninvasive Evaluation. Journal of American College of Cardiology: Cardiovascular Imaging. 2014; 7(12):1251-65. https://doi.org/10.1016/j.jcmg.2014.08.009.
9. Naksuk N., Padmanabhan D., Yogeswaran V., Asirvatham S.J. Left Atrial Appendage. Embryology, Anatomy, Physiology, Arrhythmia and Therapeutic Intervention. Journal of American College of Cardiology: Clinical Electrophysiology. 2016;2(4):403-412. https://doi.org/10.1016/j.jacep.2016.06.006.
10. Beinart R., Heist E.K., Newell J.B. et al. Left Atrial Appendage Dimensions Predict the Risk of Stroke/TIA in Patients With Atrial Fibrillation. Journal of Cardiovascular Electrophysiolgy. 2011;22(1):10-15. https://doi.org/10.1111/j.1540-8167.2010.01854.x.
11. Taina M., Vanninen R., Hedman M. et al. Left Atrial Appendage Volume Increased in More Than Half of Patients with Cryptogenic Stroke. PLoS ONE. 2013;8(11): e79519. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817123/. Accessed April 10, 2019.
12. Jeong W.K., Choi J.H., Son J.P. et al. Volume and Morphology of Left Atrial Appendage as Determinants of Stroke Subtype in Patients with Atrial Fibrillation. Heart Rhythm. 2016;13(4):820-7. https://doi.org/10.1016/j.hrthm.2015.12.026.
13. Wang Y., Di Biase L., Horton R.P. et al. Left Atrial Appendage Studied by Computed Tomography to Help Planning for Appendage Closure Device Placement. Journal of Cardiovascular Electrophysiology. 2010;21(9):973-82. https://doi.org/10.1111/j.1540-8167.2010.01814.x.
14. Di Biase L., Santangeli P., Anselmino M. et al. Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation? Results From a Multicenter Study. Journal of American College of Cardiology. 2012;60:531-8. https://doi.org/10.1016/j.jacc.2012.04.032.
15. Kimura T., Takatsuki S., Inagawa K. et al. Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores. Heart Rhythm. 2013;10(6):921-5. https://doi.org/10.1016/j.hrthm.2013.01.036.
16. Anselmino M., Scaglione M., Di Biase L et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm. 2014;11:2-7. https://doi.org/10.1016/j.hrthm.2013.10.020.
17. Korhonen M., Muuronen A., Arponen O et al. Left Atrial Appendage Morphology in Patients with Suspected Cardiogenic Stroke without Known Atrial Fibrillation. PLoS ONE; 2015;10(3):e0118822. Available at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0118822. Accessed April 12, 2019.
18. Lee J.M., Seo J., Uhm J.S et al. Why Is Left Atrial Appendage Morphology Related to Strokes? An Analysis of the Flow Velocity and Orifice Size of the Left Atrial Appendage. Journal of Cardiovascular Electrophysiology. 2015;26(9):922-927. https://doi.org/10.1111/jce.12710.
19. Gul E.E., Boles U., Haseeb S et al. Left Atrial Appendage Characteristics in Patients with Persistent Atrial Fibrillation Undergoing Catheter Ablation (Laapaf Study). Journal of Atrial Fibrillation. 2017;9(5). Available at: http://www.jafib.com/published.php?type=full&id=1526. Accessed April 20, 2019.
20. Kishima H., Mine T., Takahashi S et al. Morphologic remodeling of left atrial appendage in patients with atrial fibrillation. Heart Rhythm. 2016;13(9):1823-8. https://doi.org/10.1016/j.hrthm.2016.06.009.
21. Lee Y., Park H.C., Lee Y., Kim S.G. Comparison of Morphologic Features and Flow Velocity of the Left Atrial Appendage Among Patients With Atrial Fibrillation Alone, Transient Ischemic Attack, and Cardioembolic Stroke. American Journal of Cardiology. 2017;119(10):15961604. https://doi.org/10.1016/j.amjcard.2017.02.016.
22. Goldman М.Е., Pearce L.A., Hart R.G et al. Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: I. Reduced Flow Velocity in the Left Atrial Appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study). Journal of American Society of Echocardiography. 1999;12:1080-7.
23. Ono K., Iwama M., Kawasaki M et al. Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation. Cardiovascular Ultrasound. 2012;10:50. Available at: https://cardiovascularultrasound.biomedcentral.com/articles/10.1186/1476-7120-10-50. Accessed April 20, 2019.
24. Lee J.M., Shim J., Uhm J S et al. Impact of Increased Orifice Size and Decreased Flow Velocity of Left Atrial Appendage on Stroke in Nonvalvular Atrial Fibrillation. American Journal of Cardiology. 2014;113:963-969. https://doi.org/10.1016/j.amjcard.2013.11.058.
25. Petersen M., Roehrich A., Balzer J et al. Left atrial appendage morphology is closely associated with specific echocardiographic flow pattern in patients with atrial fibrillation. Europace. 2015;17:539-545. https://doi.org/10.1093/europace/euu347.
26. Fukushima K., Fukushima N., Kato K. et al. Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation. European Heart Journal - Cardiovascular Imaging. 2016;17:59-66. https://doi.org/10.1093/ehjci/jev117.
27. Алексеевская И.Н., Персидских Ю.А., Корнелюк И.В. и др. Факторы, ассоциированные с возникновением тромбоза ушка левого предсердия у пациентов с персистирующей фибрилляцией предсердий. Вестник аритмологии. 2009;56:20-25.
28. Zateyshchikov D.A., Brovkin A.N., Chistiakov D.A., Nosikov V.V. Advanced age, low left atrial appendage velocity, and Factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation. Journal of Thrombosis and Thrombolysis. 2010;30:192-199. https://doi.org/10.1007/s11239-0100440-1.
29. Голухова Е.З., Громова О.И., Аракелян М.Г. и др. Предикторы тромбоза ушка левого предсердия и тромбоэмболических осложнений у больных с фибрилляцией предсердий без сопутствующей клапанной патологии и ишемической болезни сердца. Креативная кардиология. 2017;11(3):262-72. doi: 10.24022/1997-3187-2017-11-3-262-272.
30. Lupercio F., Ruiz J.C., Briceno D.F. et al. Left Atrial Appendage Morphology Assessment for Risk Stratification of Embolic Stroke in Patients with Atrial Fibrillation. A Meta-Analysis. Heart Rhythm. 2016;13(7):1402-9. https://doi.org/10.1016/j.hrthm.2016.03.042.
31. Khurram I. M., Dewire J., Mager M. et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10:18431849. doi: 10.1016/j.hrthm.2013.09.065.
32. Korhonen M., Parkkonen J., Hedman M. et al. Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation/PLoS ONE 2017 12(3): e0173703. https://doi.org/10.1371/journal.pone.0173703.
33. Kelly F. R., Hull R. A., Arrey-Mbi T.B. et al. Left atrial appendage morphology and risk of stroke following pulmonary vein isolation for drug-refractory atrial fibrillation in low CHA2DS2Vasc risk patients. BMC Cardiovascular Disorders. 2017;17:70. https://doi.org/10.1186/s12872017-0504-7.
34. Calkins H., Hindricks G., Cappato R. et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;10:275-444. doi: 10.1016/j.hrthm.2017.05.012.
35. Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). European Heart Journal. 2016;3:2893-2962. https://doi.org/10.1093/ejcts/ezw313.
36. Seidl K., Rameken M., Drögemüller A., Vater M. Embolic Events in Patients With Atrial Fibrillation and Effective Anticoagulation: Value of Transesophageal Echocardiography to Guide Direct-Current Cardioversion. Final Results of the Ludwigshafen Observational Cardioversion Study. American College of Cardiology. 2002;39:1436-42. https://doi.org/10.1016/S0735-1097(02)01785-0.
37. Scherr D., Dalal D., Chilukuri K. et al. Incidence and Predictors of Left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2009;20(4):379-84. https://doi.org/10.1111/j.1540-8167.2008.01336.x
38. Wallace T.W., Atwater B.D., Daubert J.P. et al. Prevalence and Clinical Characteristics Associated With Left Atrial Appendage Thrombus in Fully Anticoagulated Patients Undergoing Catheter-Directed Atrial Fibrillation Ablation. Journal of Cardiovascular Electrophysiology. 2010;21(8):849-52. 2010 https://doi.org/10.1111/j.15408167.2010.01729.x.
39. Mitamura H., Nagai T., Watanabe A. et al. Left atrial thrombus formation and resolution during dabigatran therapy: A Japanese Heart Rhythm Society report. Journal of Arrhythmia. 2015; 31(4):226-231. https://doi.org/10.1016/j.joa.2014.12.010.
40. Zylla M.M., Pohlmeier M., Hess A. et al. Prevalence of Intracardiac Thrombi Under Phenprocoumon, Direct Oral Anticoagulants (Dabigatran and Rivaroxaban), and Bridging Therapy in Patients With Atrial Fibrillation and Flutter. American Journal of Cardiology. 2015;115:635-640. https://doi.org/10.1016/j.amjcard.2014.12.016.
41. Frenkel D., D’Amato S., Al-Kazaz M. et al. Prevalence of Left Atrial Thrombus Detection by Transesophageal Echocardiography. A Comparison of Continuous Non-Vitamin K Antagonist Oral Anticoagulant Versus Warfarin Therapy in Patients Undergoing Catheter Ablation for Atrial Fibrillation. JACC: Clinical Electrophysiology. 2016;2(3):295-303. https://doi.org/10.1016/j.jacep.2016.01.004.
42. Da Costa A. D., Delolme C., Guichard J.B. et al. Comparison of Prevalence and Management of Left-Atrial Appendage Thrombi under Old and New Anticoagulants Prior to Left-Atrial Catheter Ablation. American Heart Journal. 2017;193:8-15. https://doi.org/10.1016/j.ahj.2017.07.016.
43. Kawabata M., Goya M., Sasaki T. et al. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy Warfarin vs. Direct Oral Anticoagulants. Circulation Journal. 2017;81(5):645-651. https://doi.org/10.1253/circj.CJ-16-1089.
44. Wyrembak J., Campbell K.B., Steinberg B.A. et al. Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated with Non-Vitamin K Oral Anticoagulants Versus Warfarin Prior to Catheter Ablation for Atrial Fibrillation. American Journal of Cardiology. 2017;119(7):1017-1022. https://doi.org/10.1016/j.amjcard.2016.12.008.
45. Zhan Y., Joza J., Al Rawahi M. et al. Assessment and management of the Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation. Canadian Journal of Cardiology. 2018;34(3):252-261. https://doi.org/10.1016/j.cjca.2017.12.008.
46. Vidal A., Vanerio G. Dabigatran and left atrial appendage thrombus. Journal of Thrombosis and Thrombolysis. 2012;34(4):545-7. https://doi.org/10.1007/s11239-0120747-1.
47. Hammerstingl C., Pötzsch B., Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thrombosis and Haemostasis. 2013;109:583-584. doi: 10.1160/TH12-11-0821.
48. Takasugi J., Yamagami H., Okata T. et al. Dissolution of the Left Atrial Appendage Thrombus with Rivaroxaban Therapy. Cerebrovascular Diseases. 2013;36:322-323. https://doi.org/10.1159/000354315.
49. Kawakami T., Kobayakawa H., Ohno H. et al. Resolution of left atrial appendage thrombus with apixaban. Thrombosis Journal. 2013;11:26. https://doi.org/10.1186/1477-9560-11-26.
50. Рычков А.Ю., Хорькова Н.Ю., Белокурова А.В., Ярославская Е.И. Прямые оральные антикоагулянты при тромбозе левого предсердия у пациентов с фибрилляцией предсердий. Вестник аритмологии. 2018;91:60-63
51. Lip G.Y.H., Hammerstingl C, Marin F. et al. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). American Heart Journal. 2016;178:126-34. https://doi.org/10.1016/j.ahj.2016.05.007.
52. Watson T., Shantsila E., Lip G.Y. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009;373(9658):155-66. https://doi.org/10.1016/S0140-6736(09)60040-4.